000 01486 a2200409 4500
005 20250516174940.0
264 0 _c20150130
008 201501s 0 0 eng d
022 _a1943-3654
024 7 _a10.4187/respcare.02692
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBuchelli Ramirez, Herminia L
245 0 0 _aReversible pre-capillary pulmonary hypertension due to dasatinib.
_h[electronic resource]
260 _bRespiratory care
_cMay 2014
300 _ae77-80 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aDasatinib
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xchemically induced
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPhosphodiesterase 5 Inhibitors
_xtherapeutic use
650 0 4 _aPiperazines
_xtherapeutic use
650 0 4 _aProtein Kinase Inhibitors
_xadverse effects
650 0 4 _aPurines
_xtherapeutic use
650 0 4 _aPyrimidines
_xadverse effects
650 0 4 _aSildenafil Citrate
650 0 4 _aSulfones
_xtherapeutic use
650 0 4 _aThiazoles
_xadverse effects
700 1 _aÁlvarez Álvarez, Celso M
700 1 _aRodríguez Reguero, José J
700 1 _aGarcía Clemente, Marta M
700 1 _aCasan Clarà, Pere
773 0 _tRespiratory care
_gvol. 59
_gno. 5
_gp. e77-80
856 4 0 _uhttps://doi.org/10.4187/respcare.02692
_zAvailable from publisher's website
999 _c23193504
_d23193504